PAF, rather than histamine, participates in mouse anaphylactic hypotension

Pharmacology

Volumn 82, Issue 2, 2008, Pages 114-120

  Shibamoto, Toshishige ^a   Liu, Wei ^a   Cui, Sen ^a   Zhang, Wei ^a   Takano, Hiromichi ^a   Kurata, Yasutaka ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anaphylactic shock; Hepatic circulation, antigen, portal venous pressure, mouse; Histamine; Platelet activating factor

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; DIPHENHYDRAMINE; HISTAMINE; OVALBUMIN; THROMBOCYTE ACTIVATING FACTOR;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BAGG ALBINO MOUSE; CENTRAL VENOUS PRESSURE; COMBINATION CHEMOTHERAPY; HEMODYNAMICS; HYPOTENSION; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL;

ANAPHYLAXIS; ANIMALS; BLOOD PRESSURE; DIPHENHYDRAMINE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HYPOTENSION; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PYRIDINIUM COMPOUNDS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE H1;

EID: 49749084861     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141516     Document Type: Article

References (12)

1. Brown AFT: Anaphylactic shock: mechanism and treatment. J Accid Emerg Med 1995;12:89-100.
2. Patterson R, Roberts M, Pruzansky JJ: Comparisons of reaginic antibodies from three species. J Immunol 1969;102:466-475.
3. Finkelman FD, Rothenberg ME, Brandt EB, Morris SC, Strait RT: Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 2005;115:449-457.
4. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD: Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002;109:658-668.
5. Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao WH, Kume K, Fukuchi Y, Ikuta K, Miyazaki J, Kumada M, Shimizu T: Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 1998;187:1779-1788.
6. Karasawa N, Shibamoto T, Cui S, Takano H, Kurata Y, Tsuchida H: Hepatic pre-sinusoidal vessels contract in anaphylactic hypotension in rabbits. Acta Physiol (Oxf) 2007;189:15-22.
7. Shibamoto T, Cui S, Ruan Z, Liu W, Takano H, Kurata Y: Hepatic venoconstriction is involved in anaphylactic hypotension in rats. Am J Physiol Heart Circ Physiol 2005;289:H1436-H1441.
8. Liu W, Takano H, Shibamoto T, Cui S, Zhao ZS, Zhang W, Kurata Y: Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice. Am J Physiol Regul Integr Comp Physiol 2007;293:R1947-R1953.
9. Shibamoto T, Cui S, Ruan Z, Kurata Y: Effects of norepinephrine and histamine on vascular resistance in isolated perfused mouse liver. Jpn J Physiol 2005;55:143-148.
10. Barnes PJ: Histamine and serotonin. Pulm Pharmacol Ther 2001;14:329-339.
11. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL: International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997;49:253-278.
12. Cui S, Shibamoto T, Zhao Z, Takano H, Kurata Y: L-NAME augments PAF-induced venoconstriction in isolated perfused livers of rat and guinea pig, but not mouse. Prostaglandins Leukot Essent Fatty Acids 2007;76:277-283.